Literature DB >> 9396530

The vagus and recurrent laryngeal nerves in the rodent experimental model of esophageal atresia.

B Q Qi1, J Merei, P Farmer, S Hasthorpe, N A Myers, S W Beasley, J M Hutson.   

Abstract

BACKGROUND: After surgical correction of their esophageal atresia and tracheoesophageal fistula (EA-TEF), many patients exhibit evidence of esophageal dysmotility. Controversy exists as to whether the esophageal motility disorders result from denervation caused by surgery or from an inherent abnormal innervation of the esophagus.
METHODS: The present study used an Adriamycin-induced EA-TEF fetal rat model to trace the course and branching of both the vagus and recurrent laryngeal nerves. Abnormalities observed in EA-TEF rat fetuses include: (1) fewer branches from both recurrent laryngeal nerves; (2) deviation of the left vagus from its normal course below the aorta, passing behind the fistula to approach and join with the right vagus to form a single nerve trunk on the right side of the esophagus; (3) relatively few branches from the single vagal nerve trunk (composed of fibers of the left and the right vagus) on the surface of the lower esophagus.
CONCLUSIONS: Fetuses affected by EA-TEF have inherent abnormalities in the course and branching pattern of the vagus nerves as they descend through the thorax, culminating in a deficient extrinsic nerve fiber plexus in the lower esophagus. These observations may account for the esophageal motility disorders seen in patients who have EA-TEF even before surgical intervention.

Entities:  

Mesh:

Year:  1997        PMID: 9396530     DOI: 10.1016/s0022-3468(97)90457-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  20 in total

Review 1.  Animal models in pediatric surgery.

Authors:  A Mortell; S Montedonico; P Puri
Journal:  Pediatr Surg Int       Date:  2005-12-06       Impact factor: 1.827

2.  Adriamycin-Induced Models of VACTERL Association.

Authors:  D Mc Laughlin; P Hajduk; P Murphy; P Puri
Journal:  Mol Syndromol       Date:  2013-02

3.  Clinically significant gastro-oesophageal reflux following oesophageal flap repair for oesophageal atresia and tracheo-oesophageal fistula.

Authors:  A Morabito; N T Plummer; A Bianchi
Journal:  Pediatr Surg Int       Date:  2005-12-13       Impact factor: 1.827

Review 4.  Preoperative laryngotracheobronchoscopy in infants with esophageal atresia: why is it not routine?

Authors:  Kiarash Taghavi; Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2017-10-11       Impact factor: 1.827

Review 5.  The Adriamycin rat/mouse model and its importance to the paediatric surgeon.

Authors:  J Gillick; A Mortell; M Dawrant; S Giles; J Bannigan; P Puri
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

6.  Decrease of parafollicular thyroid C-cells in experimental esophageal atresia: further evidence of a neural crest pathogenic pathway.

Authors:  L Martinez; M De Ceano-Vivas; S Gonzalez-Reyes; F Hernandez; V Fernandez-Dumont; W M Calonge; E Ruiz; J I Rodriguez; J A Tovar
Journal:  Pediatr Surg Int       Date:  2004-11-27       Impact factor: 1.827

7.  The development of the proximal oesophageal pouch in the adriamycin rat model of oesophageal atresia with tracheo-oesophageal fistula.

Authors:  S W Beasley; A K Williams; B Q Qi; V N Vleesch Dubois
Journal:  Pediatr Surg Int       Date:  2004-07-13       Impact factor: 1.827

8.  Outcome in neonates with esophageal atresia treated over the last 20 years.

Authors:  Helene Engstrand Lilja; Tomas Wester
Journal:  Pediatr Surg Int       Date:  2008-03-20       Impact factor: 1.827

Review 9.  Advances in the treatment of oesophageal atresia over three decades: the 1970s and the 1990s.

Authors:  Jillian Orford; Daniel T Cass; Martin J Glasson
Journal:  Pediatr Surg Int       Date:  2004-05-18       Impact factor: 1.827

10.  The preterm piglet - a model in the study of oesophageal development in preterm neonates.

Authors:  S Rasch; P T Sangild; H Gregersen; M Schmidt; T Omari; C Lau
Journal:  Acta Paediatr       Date:  2009-10-29       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.